VRNA   $39.16  1.29% Market Open

Verona Pharma PLC
Total Cash 404.60M
totalCashPerShare 0.623
EBITDA -127.97M
Total Debt 122.20M
quickRatio 8.445
currentRatio 8.611
Total Revenue
debtToEquity 72.617
Revenue/Share
ROA -0.21826
ROE -0.56845003
grossProfits
freeCashflow -10.48M
operatingCashflow -53.84M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 22.45B
forwardPE -91.68293
floatShares 387.21M
sharesOutstanding 81.83M
sharesShort 7.94M
sharesShortPriorMonth 8.85M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.93%
Short Ratio help_outline 8.71%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 3.099
Price To Book help_outline 12.13
earningsQuarterlyGrowth
netIncomeToCommon -125.45M
trailingEps -2.00%
forwardEps -0.41%
enterpriseToEbitda -175.43
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.35 4Q 2024
institutionsCount 179
lastUpdated Nov. 7, 2024, 2:38 a.m.